Atomwise Company
Atomwise uses artificial intelligence for drug discovery. We design new molecules for the hardest targets. Our discoveries help our partners deliver better medicines faster.
Investors
Connections from
Funding Status:
Early Stage Venture
Headquarters:
United
Founded Date:
2012-01-01
Employee Number:
94
Last Funding Type:
Grant
Total Funding:
176645000.0
Estimated Revenue:
2.3
Industry:
Application Software
Investors Number:
22.0
Technology:
['BioTech & HealthTech']
Investor Type:
For Profit
Last Funding Date:
2020-10-06